Review article · 2016
Research articlePublished 2017
Using the SLE-key® Rule-Out Test in Clinical Practice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: The patient referred to a rheumatology clinic for workup of suspected Systemic Lupus Erythematosus (SLE) often presents a difficult diagnostic problem; until recently, there have been no objective tests validated to rule in or rule out SLE and the diagnosis is based on a list of criteria that may be open to interpretation. Methods: To approach this problem, a serologic rule out test for SLE was developed based on antigen microarray profiling of multiplex antibody reactivities. This SLE-key® test was developed by ImmunArray and, using stored serum samples from recognized academic centers, was validated to rule out SLE with 94% sensitivity, 75% specificity and a negative predictive value (NPV) of 93%. In clinical practice, however, patients are referred one at a time from peripheral clinical units, often with incomplete documentation. Results: We report here the usefulness of the SLE-key® test in aiding the management of a cohort of suspected SLE patients in a large clinical rheumatology practice. We compared the diagnosis and disposition of 163 referrals in whom we used the SLE-key® Rule-Out test to our typical experience with referrals before the test was available. This paper shows that the SLE-key® test provided actionable clinical information and helped us with patient management in several ways; in some patients we were able to definitively rule out a diagnosis of SLE, saving time and evaluation costs; in other patients, we were able to accelerate the diagnosis of SLE and the initiation of therapy. Conclusions: The SLE-key® Rule-Out test increased efficiency in saving undue concern, time and resources both to the patient and to the healthcare system.
Keywords
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2016
Antigen-Microarray Profiling of Antibodies in SLE: A Personal View ofTranslation from Basic Science to the Clinic
Short communication · 24 Aug 2021
Different flares in SLE patients and its clinical activites with novel biomarkers
Mini review · 10 Nov 2020
Potential Viral Model for SLE: Accelerated Polyclonal Autoantibody Production Following Theiler
Research article · 2018
Diagnostic Performance of a Combination Biomarker Algorithm for Rule-Out of Acute Myocardial Infarction at Time of Presentation to theEmergency Department, Using Heart-Type Fatty Acid-Binding Protein andHigh-Sensitivity Troponin T tests
More from this journal
The newest in Lupus: Open Access.
Perspective · 18 Dec 2025
Systemic Lupus Erythematosus: A Silent Autoimmune Challenge
Perspective · 18 Dec 2025
Medical Insights into Leukopenia and Immune Health
Short communication · 18 Dec 2025
The Science Behind Systemic Lupus Erythematosus
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalLupus: Open Access
- SubjectRheumatology
- BylineArticles whose byline prints “Donald Massenburg”
- BylineArticles whose byline prints “Justine Oldenberg”
- BylineArticles whose byline prints “Amanda Sell”
- BylineArticles whose byline prints “Tristan Krause”
- BylineArticles whose byline prints “Alvin F. Wells”

